The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center
Birmingham, Alabama 35233
1 studies enrolling now ยท 1 studies all time
What they study most
ER Positive Breast Cancer, Estrogen Receptor Positive Tumor, HER-2 Protein Overexpression, HER2 Low Breast Cancer, HER2 Low Breast Carcinoma, HER2 Mutation-Related Tumors, HER2-negative Breast Cancer, HER2-positive Breast Cancer, HER2-positive Metastatic Breast Cancer, HR Positive, Hormone Receptor Negative Breast Carcinoma, Hormone Receptor-positive Breast Cancer
Studies at this site
- PRE-I-SPY Phase I/Ib Oncology Platform Program โ Recruiting now